Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze LEXX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate LEXX investment potential.

What is LEXX stock price today?

Get real-time LEXX stock price, historical data, and price charts on Financhill. Track LEXX performance with our advanced analysis tools.

Is LEXX a good investment?

Evaluate LEXX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy LEXX stock?

To buy LEXX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of LEXX?

View detailed market capitalization data and company valuation metrics for LEXX on our comprehensive analysis page.

What is the P/E ratio of LEXX?

Use our fundamental analysis tools to view LEXX P/E ratio and compare valuation metrics with industry peers.

What are LEXX earnings?

View LEXX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Lexaria Bioscience Corp. 10K Form

Sell

LEXX
Lexaria Bioscience Corp.

Last Price:

$0.84

Seasonality Move:

28.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-04-14	10Q	LEXX/Lexaria Bioscience Corp. Quarterly
2021-01-14	10Q	LEXX/Lexaria Bioscience Corp. Quarterly
2020-10-15	10K	LEXX/Lexaria Bioscience Corp. Annual
2020-06-29	10Q	LEXX/Lexaria Bioscience Corp. Quarterly
2020-04-03	10Q	LEXX/Lexaria Bioscience Corp. Quarterly
2020-01-09	10Q	LEXX/Lexaria Bioscience Corp. Quarterly

Receive LEXX News And Ratings

See the #1 stock for the next 7 days that we like better than LEXX

LEXX Financial Statistics

Sales & Book Value

Annual Sales:	$705.9K
Cash Flow:	$-989.2K
Price / Cash Flow:	0
Annual Sales:	$0.22
Price / Book:	4.14

Profitability

EPS (TTM):	-0.57440
Net Income (TTM):	$-10.8M
Gross Margin:	$587.4K
Return on Equity:	-189.86%
Return on Assets:	-152.41%

Lexaria Bioscience Corp. Earnings Forecast

Key Lexaria Bioscience Corp. Financial Ratios

The Gross Profit Margin over the past 20 years for LEXX is 83.21%.
The Selling, General & Administrative Expenses for LEXX have been equal to 615.55% of Gross Profit Margin.
The Research & Development expenses have been 1,167.13% of Revenue.
The Net Earning history of LEXX is -1,687.41% of Total Revenues.
Per Share Earnings over the last 21 years have been positive in 11 years.

Lexaria Bioscience Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	LEXX
Website:	lexariabioscience.com

Debt

Debt-to-Equity Ratio:	0.02
Current Ratio:	3.68
Quick Ratio:	3.04

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

LEXX Technical Analysis vs Fundamental Analysis